4. EPIDEMIOLOGIA
Diagnostico primario mas frecuente
50 millones de personas en USA
HTA esencial 90%
Mayores de 55 años 90% de desarrollar HTA
5. RIESGO DE ENFEREMEDAD CARDIOVASCULAR
Relacion presion arterial/ECV continua
Incremento de 20/10 mmHg, dobla riesgo
Mayor posibilidad de:
1. IAM
2. Insuficiencia cardiaca
3. Enfermedad renal
4. Evento cerebro vascular
6. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
6
7. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
8. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
10. 35-40%
reduccion
Eventos cerebro
vasculares
Manejo
antihipertensivo
50%
20-25% IAM Insuficiencia
cardiaca
Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
11. OBJETIVOS
Reduccion de la morbi-mortalidad
Adoptar estilos de vida saludables
- Bajar de peso
- Ingesta de potasio y calcio
- Disminuir ingesta de sodio
- Actividad fisica
Disminuir TA 140/90 mmHg
Diabeticos y E. Renal TA: 130/80
12. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
13. Diureticos Tiazidicos base de terapia
antihipertensiva en la mayoria de los
estudios
Ante intolerancia o contraindicacion se
continuara otro que haya demostrado
reduccion en ECV
Adicion 2do farmaco cuando la monoterapia
a dosis adecuada falla
14. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
15. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
16. Hypertension. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Aram
V. Chobanian, George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.
17. BIBLIOGRAFIA
1. Hypertension. Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure. Aram V. Chobanian,
George L. Bakris, Henry R. Black, William C. Cushman, Lee A. Green. 2003 AHA.